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The quaternary structure of 
Thermus thermophilus aldehyde 
dehydrogenase is stabilized by an 
evolutionary distinct C-terminal 
arm extension
Kevin Hayes1,2, Mohamed Noor1,2, Ahmed Djeghader  1,2, Patricia Armshaw1,2, 
Tony Pembroke  1,2, Syed Tofail2,3 & Tewfik Soulimane1,2
Aldehyde dehydrogenases (ALDH) form a superfamily of dimeric or tetrameric enzymes that catalyze 
the oxidation of a broad range of aldehydes into their corresponding carboxylic acids with the 
concomitant reduction of the cofactor NAD(P) into NAD(P)H. Despite their varied polypeptide chain 
length and oligomerisation states, ALDHs possess a conserved architecture of three domains: the 
catalytic domain, NAD(P)+ binding domain, and the oligomerization domain. Here, we describe the 
structure and function of the ALDH from Thermus thermophilus (ALDHTt) which exhibits non-canonical 
features of both dimeric and tetrameric ALDH and a previously uncharacterized C-terminal arm 
extension forming novel interactions with the N-terminus in the quaternary structure. This unusual tail 
also interacts closely with the substrate entry tunnel in each monomer providing further mechanistic 
detail for the recent discovery of tail-mediated activity regulation in ALDH. However, due to the novel 
distal extension of the tail of ALDHTt and stabilizing termini-interactions, the current model of tail-
mediated substrate access is not apparent in ALDHTt. The discovery of such a long tail in a deeply and 
early branching phylum such as Deinococcus-Thermus indicates that ALDHTt may be an ancestral or 
primordial metabolic model of study. This structure provides invaluable evidence of how metabolic 
regulation has evolved and provides a link to early enzyme regulatory adaptations.
Found in both prokaryotes and eukaryotes, aldehyde dehydrogenases (ALDH) (EC 1.2.1.3) constitute a large 
family of NAD(P)-dependent enzymes with molecular weights of 50–60 kDa. The human genome encodes for 19 
known ALDHs1, with the basic catalysis being the oxidation of various aldehydes to their corresponding carbox-
ylic acids via the formation of a covalently bonded thiohemiacetal intermediate with the substrate2,3. The primary 
role of ALDH in humans and other mammals is the protection of the body from toxic compounds. For example, 
ALDH from liver mitochondria metabolizes acetaldehyde (ethanal), the oxidation product of ethanol by alcohol 
dehydrogenase, to acetic acid. In half of the Asian population, a single amino acid residue change inactivates the 
liver mitochondrial ALDH, causing severe alcohol intolerance. The drug disulfiram (Antabuse), which is used in 
the treatment of alcoholism, inhibits the liver mitochondrial ALDH3. In addition to its detoxification role, ALDH 
is also important for the biosynthesis of retinoic acid4 and GABA neurotransmitter metabolism5. In recent times 
ALDH have also become a prime target in cancer research due to the abnormal activity of human ALDH in can-
cer disease models6. Interestingly, this group of enzymes has a role in non-enzymatic conditions, such as osmotic 
stress reduction7 and mammalian cornea UV exposure protection8.
Enzymatically, mammalian ALDHs can broadly be classified as cytosolic (Class 1), mitochondrial (Class 2) 
and those expressed in tumor, stomach and cornea (Class 3)6,9. Nonetheless, the range of possible substrates and 
their corresponding affinity in prokaryotic enzymes preclude a similar classification.
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Despite the availability of various ALDH superfamily structures (>140 released and >20 unreleased struc-
tures), much of the attention has been on mesophilic enzymes including those of human and the archetypal 
Escherichia coli10. This is primarily due to their respective multiple roles with non-redundant independent regula-
tion. Interestingly, unlike many other systems, ALDH studies often originated in human enzymes rather than bac-
terial ones, leading to rather inaccurate descriptions of ‘atypical’ features. For example, the metabolically-specific 
lactaldehyde and phenylacetalaldehyde dehydrogenases from E. coli were only characterized robustly after the 
human ALDH1/2/3, and were found to have differing cofactor specificities, rate-limiting step and salt bridge 
tendencies10. Considering that there are ~ 300 different domain architectures within the ALDH-like clan (Pfam: 
CL0099), the substrate and cofactor specificity are far from easily predicted computationally. This is further com-
plicated by different oligomerization states.
Through site-directed mutagenesis experiments, it is known that the catalysis occurs as a five-step reaction 
mediated by three highly-conserved residues Cys302, Lys192 and Glu268 (human ALDH2 numbering), which 
corresponds to Cys295, Lys182 and Glu261 in ALDHTt. Glu268 acts as the general base necessary for Cys302 
activation through deprotonation in both the dehydrogenase and esterase reactions11. This reaction consists of (i) 
activation of the catalytic Cys302 by a water-mediated proton abstraction by Glu268, (ii) a nucleophilic attack by 
the Cys302 thiolate group on the electrophilic aldehyde, (iii) formation of the tetrahedral thiohemiacetal inter-
mediate (this deacylation step is the rate-limiting step in ALDH2, but not in others – cf.12,13) with concomitant 
hydride transfer to the NAD(P)+ pyridine ring, (iv) hydrolysis of the thioester intermediate from the previous 
step and finally (v) the dissociation of the reduced cofactor [NAD(P)H] and subsequent enzyme regeneration 
by NAD(P)+ binding. Steps (i) and (iv) very likely require a Glu268-bound water molecule to facilitate Cys302 
deprotonation and the subsequent hydrolysis of the thioester intermediate2.
Recent studies on interesting ALDHs from (hyper) thermophilic bacteria and archaea, including Geobacillus 
thermodenitrificans14, Pyrobaculum sp. (PDB ID: 4H73 and 4NMJ) (no primary citation available), Geobacillus 
thermoglucosidasius (PDB ID: 5J78)15 and the robustly characterized glyceraldehyde-3-phosphate dehydroge-
nases from Trichomonas tenax16 and Sulfolobus solfataricus17, and the presence of native ALDHTt as a contaminant 
during T. thermophilus caa3-cytochrome oxidase crystallization18, motivated us to investigate ALDHTt biochem-
ically and structurally.
In this article, we report the crystal structure of native ALDHTt and truncated mutants thereof. In contrast to 
other thermophilic ALDHs, but in agreement with mesophilic enzymes, the enzymatic characterization suggests 
the ability of ALDHTt to utilize both NAD+ and NADP+ as a cofactor. It also exhibits a broad range of sub-
strate specificity. ALDHTt contains an unusually extended C-terminal arm forming novel interactions with the 
N-terminus in the quaternary structure which interacts closely with the substrate entry tunnel. The presence of a 
full complement of both N- and C-terminal residues in ALDHTt, in a deeply branching bacterial lineage such as 
Thermus, gives a structural snapshot of the early evolution of ALDH. This lends detail as to why terminal trunca-
tions were favored in evolutionarily more advanced ALDHs.
Results
ALDHTt is a tetrameric aldehyde dehydrogenase with unique structural features. The biolog-
ically active form of ALDH is a homotetramer. In the case of ALDHTt, two copies related by a non-crystallo-
graphic symmetry (NCS) were present in the asymmetric unit. Based on PISA analysis19, however, it was clear 
that the tetramer assembly in ALDHTt consists of a combination of both NCS and crystallographic symmetry 
perpendicular to each other, forming a 222 symmetry (Fig. 1). In comparison, the calculated change in free 
energy values for the truncated mutants indicates a roughly linear trend towards destabilization of the tetrameric 
assembly. Nonetheless, this was not reflected in the analytical gel filtration elution (Supplementary Fig. S1). An 
interesting aspect of the PISA calculation is that both dimers and tetramers of ALDHTt are stable in solution 
(ΔGdiss > 30 kcal/mol), although the higher ΔGint for tetrameric assembly shifts the thermal equilibrium away 
from a dimeric assembly.
PISA interface analysis shows strong interactions between the A-B dimer, with a buried surface area (BSA) 
of 3,500 Å2 out of a total of 22,900 Å2, created by a network of 32 hydrogen bonds and 13 salt bridges. The A-C 
interface exhibits a slightly weaker interaction with a BSA of 2,770 Å2 (8 hydrogen bonds and 12 salt bridges).
The most striking feature of the tetramer is the orientation of the C-terminal arm extension in the overall 
quaternary structure. It wraps around the outside of the symmetry related dimer pair (A + D or B + C in Fig. 1) 
creating a network of hydrogen bonds and salt bridges with the opposing monomers N-terminal residues and 
oligomerisation domain. This network of bonding pulls the tail across the substrate access tunnel opening i.e., the 
tail of monomer A covers the tunnel of monomer B.
ALDHTt adopts the ALDH superfamily common structural architecture. The ALDHTt monomer is 
composed of the three domains common to all ALDHs (Fig. 1): (i) The NAD(P)+ binding domain (1–125 + 148–
261) comprising a Rossman fold, (ii) the catalytic domain (267–458) and (iii) the oligomerization domain 
(126–147 + 494–501). (i, ii) are separated by two loops, a short linker loop region containing Glu261 (261–267), 
required to activate the catalytic cysteine Cys295, and a long inter-domain linker (459–493) harboring the alde-
hyde anchor loop (464–466). This anchor loop, which has been previously shown to contain regulatory residues 
such as the substrate entry channel (SEC) mouth residue20 and the gating aromatic residue21, interacts with the 
substrate and product. The catalytic and cofactor-binding domains form a central tunnel through the monomer 
with NAD(P)+ at one side and the classical entrance for substrate on the opposite side. The catalytic residues are 
deep within the center of the tunnel ~16 Å from the cofactor binding site to Glu261 and substrate entry tunnel to 
the catalytic Cys295. The tunnel is ~5 Å in diameter at its widest point.
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NAD(P)+-binding. The co-crystal structure of ALDHTt515 was solved with NADP+ bound in the expected 
cofactor binding cleft of the monomeric subunit. As previously observed with other ALDH structures13,22–24, 
the electron density of the nicotinamide moiety was weak compared to the ADP-ribose part of the cofactor. 
Similarly to the human mitochondrial ALDH and ALDH1A25,13, the NADP+ cofactor is observed in the extended 
conformation in our structure. Comparison of the NADP-bound with apo structures did not reveal significant 
conformational changes for the adenosine pyrophosphate accommodation within the cofactor binding cleft. In 
the binding site the adenosine ribose interacts with Lys182 and Thr156. The 2′-phosphate group is positioned 
in the ceiling of the binding cleft with O2 and O3 within 3 Å distance from Glu185 carboxyl group. While these 
unfavorable contacts could result in electrostatic repulsion, the 2′ phosphate is stabilized by hydrogen bonds with 
the Glu185 backbone amide group in addition to Ser184 and Lys182 side chains. The pyrophosphate moiety is 
hydrogen bonded to the backbone amide group of Ser240, its side chain and to the Arg342 sidechain. Finally, the 
nicotinamide ribose has O2 and O3 hydrogen bonded with Glu404, while its carboxamide nitrogen is hydrogen 
bonded to Leu262 (Fig. 2A).
The nicotinamide ring is pointed into the catalytic pocket, in an extended “hydride transfer” conformation in 
both monomers A and B. The most notable difference between the NADP-bound and apo structures is observed 
near the catalytic residues. Indeed, in NADP-bound structures, Glu261 sidechain is in the “intermediate” confor-
mation allowing the nicotinamide ring to sit on the bottom of the catalytic tunnel, while Cys295 is observed in 
the nucleophile “attacking” rotamer. This is a classical conformation associated with NAD(P)+ bound enzyme23,25. 
Glu261 has moved from the “In” position, where it is suitably oriented for the acylation step and the deprotona-
tion of the catalytic thiol, to an intermediary space to allow entry of the nicotinic moiety and the transfer of a 
hydride from the oxyanion thiohemiacetal intermediate. However, in the native structure, Glu261 has the “In” 
conformation, associated with proton abstraction from the thiol prior to substrate binding (Fig. 2B). As previ-
ously observed in the human ALDH2 and Ct-FDH structures, Glu261 is suitably oriented and within a short 
distance to Cys295 (Fig. 2C) to act as a general base for its activation26–28. Although the Glu261 side chain can 
Figure 1. Top. ALDHTt monomeric and tetrameric domain architecture in ribbon illustration. Monomer 
A consists of the catalytic domain (green), NAD(P)+ binding domain (blue), short linker loop (yellow), 
inter-domain linker (orange), oligomerisation domain (cyan) and the C-terminal tail (red). Bottom. Surface 
representation of the tetrameric assembly of ALDHTt showing intimate relationship between protomers. 
Coloring for monomer A’s domains is kept consistent to aid orientation. Monomers B, C and D are colored in 
purple, light brown, and pink respectively.
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be modeled correctly for the native structure, it shows a weak electron density for a buried residue. This weak 
electron density, as observed with other ALDHs29, was even absent beyond the Glu261 Cβ of the recombinant 
proteins, highlighting the flexibility of this key residue. In addition, the catalytic Cys295 side chain of the native 
structure is observed in two different conformations, the “attacking” conformation and the “resting” conforma-
tion where the side chain is rotated away from the Glu261 (Fig. 2C). In the latter conformation, the sulfur group 
of the catalytic cysteine has been shown to be covalently bound to the C4 carbon of the nicotinamide ring in the 
case of Ct-FDH26.
A role for linker loop residues Leu262 and Gly263. Besides the catalytic residues orientation upon 
cofactor binding, another part of the structure seems to undergo subtle movements during catalysis. Indeed, 
our crystal structures show differences in the orientation of Leu262 and Gly263 backbone amide and carbonyl 
groups. In the apo structures, the “In” orientation of Glu261 is associated with a hydrogen bonding between one 
of the Glu261 oxygens and the amide group of Gly263 (Fig. 3 and Supplementary Fig. S2). This interaction, when 
the Glu261 side chain is visible, is seen in monomer B of the apo structures. However, in monomer A and in the 
NADP-bound structure, a local 180° flip of the main chain bring the carbonyl group of Leu262 toward the cofac-
tor binding site, making a hydrogen bond with the carboxamide nitrogen of the nicotinamide.
Product release from the catalytic tunnel. The recombinant wild type crystals yielded a structure with 
a product molecule, propanoic acid, in monomer A and B. The product is ~6 Å from the catalytic thiol, which 
is in the attacking conformation, while the Glu261 can be observed in the “In” conformation in monomer B. 
Interestingly, the ligand, situated inside the aldehyde anchor loop within hydrogen bonding distance to Arg294, 
Thr296, Gly464 and Ala465, is observed in two different orientations (Fig. 4A,B and Supplementary Fig. S3). In 
monomer B, the carboxyl group of the propanoic acid is oriented toward the catalytic cysteine and is coordinated 
by hydrogen bonds with Arg294, Thr296 and Gly464. However, in monomer A the carboxyl group of the product 
is now oriented toward the aldehyde anchor loop and coordinated by the same residues as in monomer B in addi-
tion to Ala465 and Thr462 through a water-mediated hydrogen bond.
C-terminal arm interactions and significance. The tail of ALDHTt starts after the oligomerization 
domain and terminates in a 3-turn helix, which interacts with the N-terminal residues of its opposing monomer 
(A-D). The novel orientation of the tail contributes to salt bridge formation and hydrogen bonds between mono-
mers A/B and A/D. This is governed by three pivot or fulcrum points on the tail (Fig. 5). In the available structures 
on the PDB, ALDHs with extended C-terminal are observed; however, their tails are sensibly shorter and do not 
interact with N-terminal residues of the other monomers (Supplementary Fig. S4).
Figure 2. NADP+ binding and catalytic residues conformations in ALDHTt. (A) NADP+ binding highlighting 
hydrogen bonding. The cofactor and interacting residues are in stick representation, the FoFc omit map of 
NADP+ contoured at 3 sigma is shown as green mesh. (B) Close up view of Glu261 positioning in native 
(orange) and ALDHTt515 structures (Cyan). The catalytic cysteine 295 is shown for the native structure. The 
cofactor is shown to highlight the Glu261 movement induced by cofactor binding. (C) Superimposition of 
ALDHTtNative and Ct-FDH structures (PDB code2O2P) showing similarities between the two structures 
in terms of Glutamic acid orientation and proximity to the catalytic cysteine which is present in double 
conformation.
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The ALDHTt tail begins in the cleft between the catalytic and cofactor binding domains. It makes an immedi-
ate turn at Ser503 and Gly504 (referred to as the “Notch” in Fig. 5A) and deviates from the well-studied dimeric 
tail folding orientation wrapping with the N-terminal residues of another monomer. This sharp turn makes the 
tail run perpendicular to the direction of the inter-domain cleft and directly over the substrate access tunnel. 
The section of the tail blocking the SEC mouth is known as the “Crook” (Fig. 5A). In ALDHTt this pivot is made 
possible through interactions between Leu508 main chain and Asp512 amine group and side chain. The SEC is 
tightly locked by the side chains of Ala509 and Gln510 pointing into the pore. Gln510 forms a hydrogen bond 
with Ala465 on the aldehyde anchor loop (Fig. 5B). This interaction suggests that the tail plays a role in active site 
regulation30.
The ALDH7A1 tail is far shorter than its ALDHTt counterpart and has adequate space to make a 16 Å sweep 
away from the tunnel entrance (Fig. 5C). The movement occurs at the “Notch” region which is characterized by 
the presence of asparagine and serine residues (Glu501 and Ser503 in ALDHTt) interacting together via a hydro-
gen bond. In ALDHTt an additional salt bridge between Gln507 and Glu501 further stabilizes the “Notch” region. 
The current ALDHTt structures do not indicate that this movement is possible due to the increased length and 
differing orientation. The tail does not make the distinctive “L” shape reported for ALDH7A1. It rather deviates 
again in the “Hook” region creating a straight line path from oligomerisation domain to the N-terminus of a 
Figure 3. Linker loop residues orientation. Structures superimposition showing linker loop residues 
orientations in native (Cyan) and NADP+ bound (Orange) structures. The catalytic cysteine is in the attacking 
conformation for both structures, while the glutamic acid is in the “In” conformation for the native structure or 
the intermediate conformation for the NADP-bound structure. The orientation of the residues from the linker 
loop Leu262 and Gly263 is shown. The hydrogen bound stabilizing the glutamic acid is shown in dashes.
Figure 4. Propanoic acid in the substrate entry channel. (A) Product binding in monomer A of the full 
length recombinant ALDHTt. The residues of the anchor loop (Cyan) are shown in stick and labeled. Potential 
hydrogen bonds between the propanoic acid (Green) and the protein residues are shown. (B) Product binding 
in monomer B, highlighting a different orientation of the carboxyl group. Glu261 orientation is shown only 
when the side chain was visible in the structure. The distance between the propanoic acid and the cysteine 
residue is shown in both structures.
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neighboring monomer. The “Crook” of the tail (Leu508-Gln510) is conserved in both structures as well as the 
interacting anchor loop residues (Gly464-Glu466). This conservation is thought to be a defining characteristic 
of family 7 of the ALDH superfamily, so it is possible that ALDHTt should be classified in family 7. In all ALDHTt 
structures, where the tail is persistently closed, the anchor loop is also closed. The ALDH7A1 structure terminates 
four residues after the “Crook” allowing room for the tail to fold into a hydrophobic pocket in the side of the cat-
alytic domain. However, the ALDHTt terminates twenty residues after the “Crook” leaving insufficient space for a 
long tail to fold away from the substrate entrance tunnel. This swinging of the tail into an open position is unlikely 
in ALDHTt, due to Lys105 pointing up into the interdomain cleft (Figs 1 and 5D).
Salt bridge mediated tail-oligomerization domain interactions. The wrapping of the tail around 
the outside of the tetramer, via the “Hook”, and blockage of the substrate access tunnel via the “Crook”, is medi-
ated by a network of hydrogen bonds and salt bridges between the oligomerisation domains and the tails. These 
interactions keep the entire tail pressed against the monomer interfaces (A-B-D), strengthening them and making 
it far stronger than mesophilic counterparts. The linchpin of these interactions revolves around an additional 
salt bridge in the oligomerisation domain of each monomer, Arg126-Glu136. The Arg126 of monomer D points 
toward the pivotal tail fulcrums and creates a central interaction point between the “Crook” and “Hook” on 
Figure 5. Comparison of ALDH tail orientations with regard to the substrate entry tunnel and fulcrum 
points on the tails. (A) Superimposition of ALDHTt (Red), Human dimeric ALDH3 (PDB: 3SZA, magenta) 
and tetrameric ALDH7A1 in the closed and open conformations (PDB: 4ZUL, yellow; 4ZUK, light blue 
respectively). Highlights how all previously characterized tails fold at the crook or notch and rest in the 
interdomain cleft (domain coloring of Fig. 1 used) whilst ALDHTt is orientated across the tetramer interface 
and away from the other tails after the hook. (B) Close up of the substrate entry channel showing interaction 
between the C-terminal tail Gln510 of monomer B (brown) with Ala 465 of monomer A (Cyan) in ALDHTt. (C) 
Comparison of human ALDH7A1 and ALDHTt. Domain coloring is kept consistent with Fig. 1 for orientation 
purposes. The human dehydrogenase in the closed position can swing out away from the substrate entrance 
channel into the open conformation and fold into the interdomain cleft and against the catalytic domain 
due to its size whilst ALDHTt’s extended tail makes this impractical. (D) A magnified view of ALDHTt SEC is 
shown highlighting the positively charged K105 packing against the negatively charged hook of the tail and not 
allowing the tail to fold like those previously characterized. The crook is seen to be firmly over the SEC. NADP+ 
is depicted in stick within the tunnel.
www.nature.com/scientificreports/
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the tail of monomer A, the anchor loop of monomer B and the oligomerisation domain of monomer D. The 
Arg126-Glu136 is thought to be the strongest of salt bridges31, in other ALDHs the arginine is replaced with an 
aspartic acid incapable of forming a salt bridge with the negatively charged glutamic acid. This salt bridge stabi-
lizes the tail of each monomer by mediating hydrogen bonding between Glu136 and Gln510, which holds the tail 
in place over the substrate access tunnel. The rest of the tail is characterized by the presence of three proline res-
idues in positions 518, 521 and 523, hindering the formation of any secondary structures. Finally, the tail is held 
on the surface and interacts with the N-terminal of monomer D through hydrogen bonds involving main chain 
amine and carbonyl groups. A summary of these interactions is shown in Supplementary Fig. S5.
To probe the significance of the tail and its fulcrum points, two truncated tail mutants were made: (i) 
ALDHTt515 which removes all residues distal to the “Crook & Hook” and (ii) ALDHTt508, a mutant which 
removes the “Crook & Hook” entirely but retains the “Notch” to try and model other tail containing ALDHs. It 
was expected that at least one of the truncated mutants of ALDHTt could produce an open conformation of the 
protein and obtain substrate/product bound structures. However, ALDHTt mutants could only be crystalized in 
a closed and compact conformation. ALDHTt515 demonstrates no movement in the anchor loop or salt bridge 
interactions, leading us to believe that the last 15 residues of the protein play a minor role in the active site regu-
lation. The ALDHTt508 structure is “open” as the “Crook” of the tail has been removed, but there is still no move-
ment in the anchor loop to an open position. It is worthy to note that the electron density maps were of a reduced 
quality in the C-terminal region of the truncated mutants compared to the native or the full length recombinant 
proteins, highlighting the role of the extended C-terminal tail in stabilizing the overall structure.
Comparison with homologous sequences (Table 1) shows that the T. thermophilus HB8 strain is the only 
one with a significantly shorter tail within its genus (515 vs. 530 residues). Within the Deinococcus-Thermus 
phylum, however, not all are thermophilic bacteria. A careful DELTA-BLAST search against all structures in 
the PDB indicated the absence of a similar long C-terminal tail. Nonetheless, this tail is present not only within 
the Deinococcus-Thermus phylum (Table 1), but also in several other organisms including Bacillus stratospheri-
cus (GenBank: EMI11952.1; 539 residues), Pyrinomonas methylaliphatogenes (GenBank: CDM65952.1; 545 
residues) and Thermaerobacter marianensis (GenBank: ADU51624.1; 552 residues). Despite a similar extensive 
search using only the C-terminal tail sequence (EYSGRLQLAQMDTGYVSPKAPTPWGEVLGL) against pro-
tein sequences outside the Deinococcus-Thermusphylum, only a partial sequence from Kouleothrix aurantiaca 
(GenBank: KPV51990.1; a member of the Chloroflexi phylum of filamentous green non-sulfur bacteria) was 
identified as containing the fragment SGKLQLAQMDTDYIAPKSP.
The central pore of the tetramer. In the native crystal structure two partially occupied and mutually 
exclusive n-octyl-β-glucoside (BOG) molecules originating from the detergent used for caa3-oxidase purification; 
(cf. Materials and Methods) are found deep within the centre of the tetramer. They lie in a highly positive pore 
created by the oligomerisation domain and inter-domain linkers of each monomer. Pores and tunnels also exist 
between monomer interfaces in the tetrameric assembly and these interfaces are highly positively charged in the 
ALDHTt structure, far more so than many other known ALDH structures (Fig. 6 and Supplementary Fig. S6).
Clade ID Organism Accession Locus_tag Length (aa)
20358 Deinococcus proteolyticus MRP WP_013623073 Deipr_2214 539
20699 Holophaga foetida DSM 6591 WP_005036551 HolfoDRAFT_1243 537
20356 Marinithermus hydrothermalis DSM 14884 WP_013704042 Marky_1255 533
20349 Meiothermus ruber DSM 1279 WP_013013654 Mrub_1373 529
20350 Meiothermus silvanus DSM 9946 WP_013158503 Mesil_2080 530
21980 Meiothermus timidus DSM 17022 WP_018465841 B047_04905 535
20355 Oceanithermus profundus DSM 14977 WP_013457786 Ocepr_1159 530
20352 Thermus aquaticus Y51MC23 WP_003045659 TaqDRAFT_5353 530
22722 Thermus igniterrae ATCC 700962 WP_018112318 B128_10945 530
21982 Thermus oshimai DSM 12092 WP_018460723 B043_01690 530
21982 Thermus oshimai JL-2 WP_016328881 Theos_0625 530
20353 Thermus scotoductus DSM 8553 WP_019550178 F604_01840 529
20353 Thermus scotoductus SA-01 WP_015717232 TSC_c13390 530
20354 Thermus sp. CCB_US3_UF1 WP_014515534 TCCBUS3UF1_11310 530
20351 Thermus thermophilus HB27 WP_011172958 TTC0513 530
20351 Thermus thermophilus HB8 WP_011228252 TTHA0865 515
20351 Thermus thermophilus JL-18 WP_014629714 TtJL18_1181 529
20351 Thermus thermophilus SG0.5JP17-16 WP_014510213 Ththe16_0870 530
20357 Truepera radiovictrix DSM 17093 WP_013178702 Trad_2228 527
Table 1. Distribution of ALDH with long C-terminal tail. All species are within the Deinococcus-Thermus 
phylum with the exception of Holophaga foetida which is a member of the Acidobacteria phylum. Only the 
ALDH from T. thermophilus HB8 has a significantly shorter C-terminus.
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In the tetramer, there are four tunnels leading to this central pore. The tunnel openings consist of residues 
from the cofactor binding domain of one monomer and residues from the interdomain linker and catalytic 
domain of another. These tunnels are again ~15 Å in length before reaching a central junction and accessing a 
shared tunnel leading to the pore which is ~25 Å in length. The maximum diameter of these tunnels is similar to 
the substrate access tunnel, 3.0–3.2 Å.
The central cavity is composed of residues from the interdomain linker, oligomerisation domain and the 
C-terminal tail. There is hydrogen bonding between the head group of the BOG and the positively charged 
sidechain of Arg127 on the junction between the oligomerisation domain and cofactor binding domain which 
is positioned directly beside Arg126 which we believe to play a crucial role in tail orientation and thus active site 
access.
Enzyme kinetics. As the cofactor used in any enzyme assay has a significant effect on its readout, we first 
determined the preferential cofactor using a set of substrates for the recombinant wild type enzyme ALDHTt530. 
The ALDH activity was consistently higher with NAD+ with a specific activity of 0.965.8 ± 0.043 U mg−1 com-
pared to with NADP+ at 0.322 ± 0.059 U mg−1 at 50 °C (Supplementary Table S1). Secondly, we also defined the 
optimal pH value for the assay, within a range of pH 6.0–8.0 using Kpi buffer with the highest activity being at 
pH 8.0 (data not shown). Further assays were performed at both mesophilic temperature (25 °C) and elevated 
thermophilic-like temperature (50 °C). Although T. thermophilus grows best at 70 °C, a lower temperature was 
used in the assays to minimize evaporation of certain volatile substrates and maintain stable readings.
Figure 6. Positioning of BOG in the native structure deep within the tetramer. (A) Surface representation 
of the tetramer in which monomer B has been removed for clarity purposes. The two BOG molecules (in 
stick representation) are deeply buried within the tetramer. Note that BOG molecules lie between the inter-
domain linker and the oligomerization domain (Orange and cyan, respectively for monomer A). Coloring for 
all monomers is kept consistent with Fig. 1 to aid orientation. (B) Yellow dashed ellipse highlights the highly 
positive tunnel which exists between monomer interfaces.
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Interestingly, both truncated mutants ALDHTt508 and ALDHTt515 were slightly more active (specific activity 
of 1.068 ± 0.004 and 1.069 ± 0.012 U mg−1, respectively, Supplementary Table S1) than the recombinant wild 
type enzyme at 50 °C (0.965 ± 0.043 U mg−1), perhaps due to the presence of small amounts of ammonium sul-
fate acting as a stabilizing agent. Attempts to assess enzymatic activities at the higher temperature of 85 °C were 
not successful as both mutants rapidly lost their function compared to ALDHTt530 where it was still active up to 
4 min, consistent with the Tm of ALDHTt530 of 84 °C. Taken together, the relative stability of the recombinant 
enzymes was in the order ALDHTt530 > ALDHTt515 ≈ ALDHTt508 (Supplementary Fig. S7).
Discussion
The structures described here show a unique tetrameric organization for ALDH. Indeed, ALDHs are known to 
form dimer-of-dimers tetramer. However, the presence in ALDHTt of an unusual extended arm that wrap the 
facing monomer through H-bonds and salt bridges shows for the first time how the tetramer is not merely a 
dimer-of-dimers carrying out their functions independent of each other, but that the interaction of the N- and 
C-termini in CS-related monomers may regulate active site access in NCS-related molecules.
ALDHs are NAD(P)+ dependent enzymes. Structurally, the NAD(P)+ binding sites do not belong to a single 
common family as classified in32 with ALDHTt situated in Group III_NADP family. Due to the poor discrimina-
tory power of this family, it is not possible to state whether the enzyme binds to NAD+ and/or NADP+ on the 
basis of sequence alone. Despite the co-crystals of the truncated mutant ALDHTt515-NADP+ being significantly 
larger and better diffracting than those with NAD+, enzyme kinetics data described in this work indicates that the 
preferential cofactor is NAD+. In addition, these data are supported by the observed proximity of the 2′ phosphate 
to Glu185, which gives the structural basis for NAD+ preference in ALDHTt.
The structure of ALDHTt with NADP+ shows no major conformational changes between the apo and 
cofactor-bound structures. The effect of NADP+ binding is observed locally on the catalytic residues Glu261 and 
Cys295 side chains which adopt classical orientations observed with cofactor bounded ALDH23,25. It is worthy 
to note here that the electron density of the nicotinamide moiety was weaker than the rest of the cofactor. This is 
mainly due to the high flexibility of this part of the cofactor, thought to sample different conformations during 
catalysis13,33–35.
Besides moving Glu261 away from the “In” position, cofactor binding induces more subtle changes in the 
active site. This concerns a 180° main chain flip around residues of the linker loop Leu262 and Gly263 which 
interact with Glu261 and the nicotinamide moiety of the cofactor, respectively. These kinds of interactions 
between the linker loop and the nicotinamide moiety, as previously reported for Ct-FDH, are believed to play 
a role in the cofactor stabilization26. Consequently, these movements are likely to play a role during catalysis, as 
they involve direct interactions with the general base Glu261 and the nicotinamide moiety of the cofactor. As 
for ALDH2, the proximity of Glu261 with Cys295 argues for a direct activation of the catalytic cysteine by the 
glutamic acid. The latter, being in the “In” conformation, is stabilized by a hydrogen bond with Gly263. Upon 
cofactor binding, Glu261 rolls back to make a place for the cofactor, this movement is accompanied by a local 
180° flip of the main chain linker loop to bring Leu262 carbonyl group toward the carboxamide nitrogen of the 
nicotinamide for stabilization. This will allow for the hybride transfer to occur, and for another 180 ° flip of the 
main chain linker loop along with “In” positioning of Glu261 following cofactor exit. This last step is supported 
by our product-bound structure where the “In” conformation of Glu261 is observed. Indeed, in the full-length 
recombinant protein Glu261 is observed in the “In” conformation, which may be indicative of an intermediate 
state depicting the molecule leaving the tunnel after catalysis, with repositioning of the glutamic acid. The differ-
ent orientations of the product in monomers A and B is likely to provide snapshots of product handling through-
out the aldehyde anchor loop. It is worthy to note that a similar product orientation was previously observed with 
ALDH1A336.
Initially, when we solved the structure of the native ALDHTt, we noticed the presence of an extended 
C-terminal tail. This is not surprising as similar extensions have been seen in the ba3-oxidase, caa3-oxidase and 
cytochrome c552 of T. thermophilus previously. In contrast, thermophilic targets are expected to have shorter loops 
and tighter packing37–39.
C-terminal tails are not uncommon in ALDHs but are most often characterized in dimeric ALDH40, with 
the exception of the human tetrameric ALDH7A130. However, in all previously reported cases, this tail is of a 
considerably shorter length and does not interact with the N-terminus of a CS-related molecule. To the best of 
our knowledge, all known tails only interact with the closest monomer in the classical dimer orientation (A/B). 
An interaction between N- and C- termini is not possible due to the fact that dimeric ALDHs have a shortened 
N-terminus and tetrameric ALDHs do not contain a tail.
Two structures in the PDB show evidence for the tail of an ALDH being involved in active site access and 
regulation. These are membrane associated human FALDH41 (PDB: 4QGK) and ALDH7A130 (PDB: 4ZUL). The 
FALDH contains a transmembrane helix (omitted from structure) and a gatekeeper helix which does not plug 
the active site entrance but merely caps it. ALDH7A1 is more similar in structure to ALDHTt as the “Crook” of 
the C-terminal tail plugs the substrate entrance tunnel firmly. Although dimeric ALDH possess a tail, it should 
be noted that in many cases the tail is not long enough to cap or plug the substrate access tunnel. In cases where it 
is long enough, it folds along the edge of the tunnel opening without ever interacting with the substrate entrance 
channel mouth residues.
In all tail containing ALDHs characterized thus far, the apo and cofactor bound proteins were in an open 
conformation. A closed conformation could only be found in product bound ALDH7A1. Surprisingly, ALDHTt 
could only be crystallized in a closed tail conformation in the apo and holoenzyme. The difference in resting 
conformations between ALDHTt and other ALDHs may be indicative of an allosteric regulation mechanism such 
as the model seen for non-phosphorylating GAPN16 or the requirement of stabilizing ligands between monomer 
interfaces42.
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The longer tails in ALDHs were postulated to effect solubility in medically significant mutations such as 
c.1512delG which leads to pyridoxine-dependent epilepsy30,43. We would like to note that our truncated mutants 
were of a much lower solubility than full length recombinant or native proteins highlighting the significance of 
the N- and C-termini interactions in the quaternary structure. We also investigated the tail extension as an obvi-
ous thermal clamp in a thermophilic genus such as Thermus however, no significant reduction in Tm (<5 °C) was 
seen during thermal shift assays. This is unsurprising when it is noted that an ALDH of 515 residues in length 
exists in the close relative, T. thermophilus HB8. Such a protein would still contain a full complement of “Crook & 
Hook” tail residues allowing for active site regulation and may even perform more efficiently as it may be able to 
fold more easily into inter-domain clefts without the cumbersome longer tail.
The similarity in tail orientation and active site regulatory loops between ALDHTt and its deletion mutant 
structures even without intermolecular interactions between the end of the tail and N-terminal interactions hints 
that active site access is regulated by additional domain interactions. It must be noted that the similar crystalli-
zation conditions and thus uniform space group may only allow for the closed and compact conformation of the 
protein. Phylogenetically, we hypothesize that the ancestral ALDH possessed both extended N- and C-termini, 
but either terminus was lost due to no evolutionary pressure being present in accordance with the potentially 
cumbersome regulation model needed in ALDHTt. Our structural data shows for the first time a clear rationale 
highlighting that ALDH first evolved with both extended N-termini and then diverged as either terminus was 
truncated.
The presence of longer tails in mesophilic bacteria belonging to the Deinococcus-Thermus phylum suggests 
that the presence of this C-terminal tail must have been chosen by evolution for specific functional reasons not, 
entirely, due to its habitat of high temperature. The very limited number of sequences with an extended c-terminal 
tail found outside the Deinococcus-Thermus phylum may argue for a phylum-specific adaptation that could have 
been subsequently lost over the course of evolution, especially considering that this phylum is rather ancient.
The oligomeric state of ALDH poses an obvious question as to the reason for the conservation of a tetrameric 
assembly even when the protomers are far apart in the three-dimensional so as to preclude any direct electron 
transfer (cf. for instance, ubiquinone:cytochromec oxidoreductase/bc1 complex44). Consequently, an alternative 
explanation must be considered – the extensive contacts made by the oligomerization domain potentially pro-
vide a structural stability even when the living conditions are not extreme. In this regard, the ‘ancient’ tetrameric 
assembly was not lost when this enzyme was retained in human and other mesophilic organisms.
For human ALDH, the C-terminal arm confers only a stability enhancement but is not an 
oligomerization-triggering element. This is the reason that the deletion of the ALDH3 tail, addition of various 
tails in ALDH1, and mutations at the dimer-dimer interface failed to convert one natural state to another45, in 
line with previous observations that the protein stability and folding are effected by the N-terminal residues46,47. 
Nonetheless, given the magnitude of free energy change upon tetramerization, we could not isolate a dimeric 
variant of ALDHTt in a pH- and cofactor-dependent manner in contrast to the horse liver enzyme3,12.
Another intriguing observation with ALDHTt is the presence of BOG molecules at the dimer-dimer interface. 
These BOG molecules have been modelled at partial occupancy which suggests that the detergent molecules 
sample several conformations in the tetramer’s pore. BOG has been used previously to study the cornea crys-
tallin ALDH and was noted as being mild and non-interfering with regards to the quaternary structure48,49. The 
adventitious binding of detergents as additives in soluble proteins or as lipid mimics in membrane protein crys-
tallisation is not uncommon and often is overlooked as having any biological significance. However, the presence 
of BOG deep within the tetramer assembly of ALDHTt is interesting as its positioning, with respect to the rather 
inflexible and closed position of the tail, begs the question as to how it entered
It could hardly be suggested that the BOG molecules entered the central pore of the tetramer via one of the 
tunnels present in the structure. Indeed, these tunnels are not of a sufficient size to allow the bulky glucose head 
group of a BOG to enter and make its way to the central pore, so an alternative conformation or access pathway 
must exist. Another possibility is that: (1) the tail swings away from the wall of the central pore attempting to 
allow substrate to enter into the monomeric subunit (2) the BOG cannot fit into the monomer so continues into 
the positively charged pore and (3) the tail closes again sequestering the detergent inside. One final possibility 
may be that the detergent has split the tetramer into dimers; however, this seems unlikely as there is no presence 
of detergent molecules on the other surfaces of the protein and BOG has been shown to be mild towards ALDH 
in the past. The presence of two conformations of detergent molecule most likely points to the two positions of the 
molecules when they enter from opposing interface tunnels. The negative head group of the detergent molecule 
is attracted to this charged pore and then becomes trapped in the central cavity. It is tempting to postulate that 
this highly charged pore is not coincidental and that this is a possible allosteric regulation site for ALDHTt which 
allows access to the substrate tunnel of each monomer.
Interestingly, the truncated mutants were kinetically more active than the full-length ALDHTt. The occlusion 
of the active site by the C-terminal arm in ALDHTt530 could be the reason for the increased activity in the trun-
cated enzymes but the crook and hook fulcrums are still present in ALDHTt515 so this was expected to also have 
a similar activity to the recombinant wild type. The higher activity in the truncations may be explained by the 
easier folding of the tail away from the SEC like other ALDH discussed above but our structural data contradicts 
the movement. It may be the case that a folded or open crook and hook portion of the tail may exist during the 
in vitro assay, but the current crystallization conditions do not stabilize such a conformation during structural 
studies. Regardless, this higher activity is not observed at the higher temperature of 85 °C as both mutants rap-
idly lost their function compared to ALDHTt530 where it was still active up to 4 min, consistent with the Tm of 
ALDHTt530 of 84 °C.
Extrapolating our data herein to other previously-characterized enzymes is not possible as mesophiles and 
thermophiles have different optimal temperature. Another reason for a reserved comparison of ALDH is that 
the true substrate for many has not been identified and as such cannot be compared with ALDH kinetic data 
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for enzymes with their actual physiological substrate defined. For instance, the extensively-studied E. coli alde-
hyde dehydrogenase, AldB, has a KM of 5.8 µM with the substrate propanal42, compared to the ALDHTt530 KM 
of 2.76 mM (data not shown). Perhaps a more straightforward comparison would be with the enzyme from T. 
thermophilus HB8.
An ALDH in T. thermophilus HB8, which forms a complex with an aldolase and occupies an interesting sub-
class of the ALDH superfamily50 also had its kinetic parameters defined at 25 °C with a KM = 6.4 mM compared to 
the ALDHTt530 KM = 2.76 mM when propanal was used. However, a much more kinetically active enzyme exists 
in another thermophilic bacteria, Geobacillus thermodenitrificans, which is reported as having a KM of 6.6 µM 
using acetaldehyde at 60 °C14. Again, this increased kinetic ability may be due to the higher temperature but when 
attempted at 60 °C we could not obtain reliable data due to the volatile nature of the aldehydes.
Materials and Methods
Native ALDHTt protein purification and crystallization. Crystalline native ALDH from T. thermo-
philus was identified as an impurity, via Edman degradation (deformylated) and mass spectrometry, during the 
crystallization of the caa3-cytochrome c oxidase whereby the oxidase and ALDHTt crystals grew in the presence 
of polyethylene glycol and ammonium sulfate as precipitating agents, respectively18. ALDHTt was purified from 
the caa3-oxidase by cation exchange chromatography and ammonium sulfate precipitation. Suitable bipyrami-
dal crystals from 20 mg/ml solution were obtained by the sitting-drop vapor diffusion method at 20 °C, against 
50 mM MOPS pH 7.5 and 1.2 M ammonium sulfate.
Cloning, production and crystallisation of wild type recombinant ALDHTt and its truncated 
mutants. Primers used for amplification and cloning of the gene encoding for ALDHTt (TTC0513; Accession 
ID: WP_011172958) into the pET-22b (+) vector are summarized in Supplementary Table S2.
The construct DNA for each of the wild type and truncated mutants of ALDHTt were transformed into 
Escherichia coli BL21 Star (DE3) competent cells (Invitrogen). The auto-induction ZYM-5052 medium51, supple-
mented with ampicillin (100 µg/ml), was inoculated with an overnight culture of the transformed cells at 1% (v/v), 
and grown for 48 h at 25 °C with shaking at 200 rpm.
Cells were collected by centrifugation (6500 × g, 15 minutes, 4 °C) and washed in 500 ml of 20 mM Tris-HCl 
pH 7.5, 5 mM β-mercaptoethanol, 10 mM imidazole and 500 mM NaCl. Following a second centrifugation step, 
the cells were resuspended in the same buffer supplemented with Lysozyme (1 mg/ml) and 5 mM EDTA pH 
8.0 and stirred at room temperature for 1 h. DNase (0.1 mg/ml) was then added along with 5 mM MgCl2 and 
the cells were gently stirred at 4 °C for 1 h and sonicated in an ice-water bath for 20 min. Finally, the mixture 
was heated to 65 °C for 15 min and centrifuged at 25,000 × g, 30 min, 4 °C). The supernatant was then loaded 
onto an XK 16/20 column containing Ni Sepharose 6 Fast Flow (GE Healthcare) pre-equilibrated with 20 mM 
Tris-HCl pH 7.5, 5 mM β-mercaptoethanol, 10 mM imidazole and 200 mM NaCl. Bound proteins were eluted 
using a step gradient of 60, 100, 250 and 500 mM of imidazole in 20 mM Tris-HCl, 5 mM β-mercaptoethanol and 
150 mM NaCl, pH 7.5. Fractions containing the protein were then dialyzed overnight in 50 mM Tris-HCl, 5 mM 
β-mercaptoethanol and 250 mM NaCl, pH 7.5 prior to concentration using Amicon Ultra-15 centrifugal filters, 
50 kDa MWCO (Merck Millipore) and loaded onto a HiLoad 16/60 Superdex 200 pg column pre-equilibrated 
with 50 mM Tris-HCl pH 7.5, 5 mM β-mercaptoethanol and 150 mM NaCl.
All crystallization assays were realized in the same conditions as for native ALDHTt. Co-crystallisation of 
ALDHTt515 with NAD(P)+ and ALDHTt530 with propanal were achieved by adding 1 mM of NAD(P)+ sodium 
salts and 50 mM of propanal to the respective drops.
Structure solution of ALDHTt native and recombinant proteins. Datasets were collected at the 
Diamond I04 and I24 beamlines. Data were processed using xia2/XDS52–54 and high resolution cut off were 
selected according to Karplus & Diederichs55. For ALDHTtnative, 6 X-ray diffraction data were collected from 
multiple crystals, each having different effective maximum individual resolution as determined by the CC1/2 at 
the CORRECT stage. With the availability of multiple highly-diffracting isomorphous crystals, it was possible 
to merge and scale the datasets using XSCALE into a single dataset. Phasing was achieved through molecular 
replacement (phenix.MRage/Phaser)56 using multiple search models. The best solution was obtained with the 
human ALDH1A1 (PDB ID: 4WJ9)57 in the space group P41212. The partial model was automatically built using 
Phenix.AutoBuild58, improved manually with Coot59 and refined with phenix.refine60 and Refmac61. The obtained 
model was used to resolve the structure of the recombinant proteins. Phenix.Ligandfit was used to automatically 
place ligands in the structures. Data collection and refinement statistics are shown in Supplementary Table S3.
Thermofluor assay. A thermofluor assay was used to assess the relative thermostability of the ALDHTt sam-
ples. The dye Sypro orange (Invitrogen) and a qPCR machine (Roche Light cycler 480) with an excitation filter of 
498 nm and an emission filter of 610 nm were used. Samples were equilibrated at 25 °C for 3 min before a ramped 
heating step between 25–95 °C. The heating rate was set to 0.03 °C/s corresponding to 20 acquisitions/°C. The first 
derivative and Tm were plotted using OriginPro 9.1.
Enzyme kinetics. Enzyme assays were performed over a short period of time to ensure no evaporative loss 
of the volatile aldehydes. The standard assay condition was chosen and optimized from the conditions which gave 
the largest and most stable change in the fluorescence readings. The standard enzyme assay consisted of 10 mM 
KH2PO4-K2HPO4 (Kpi) pH 8.0, 0.4 mM NAD+, 60 nM ALDH, 1 mM hexanal, in a total volume of 0.5 ml unless 
otherwise stated. A substrate-lacking reaction was used as a negative control. The reaction was monitored at 50 °C 
for 60 s. The reduction of NAD+ cofactor to NADH was monitored in a Cary fluorescence spectrophotometer 
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(λexcitation = 340 nm; λemission = 463 nm) with respective slit widths of 20 nm and 5 nm. All components were heated 
before being added to the cuvette and the reaction was started with the addition of substrate. One unit of enzyme 
was defined as the amount of enzyme which catalyzed the formation of 1.0 µmol of NADH/min. All assays were 
performed as a minimum of two independent experiments with triplicates for each reaction. Kinetics data and 
curve fitting were performed using OriginPro 9.1.
Figure generation and data deposition. All the figures were generated with Pymol (DeLano Scientific, 
South San Francisco, CA) and CCP4mg62. The atomic coordinates and structure factors for ALDHTt native, 
ALDHTt530 in complex with propanoic acid, ALDHTt515 in complex with NADP and ALDHTt508 have been 
deposited in the Protein Data Bank www.pdb.org (PDB ID: 6FJX, 6FK3, 6FKU and 6FKV, respectively).
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